My guest this week is Alice Shaw, a mid-twenties City lawyer who talks honestly and powerfully about her experience of juggling life alongside the world of eating disorders. She shares how she first fell down the slippery slope of restrictive eating, her experience with therapy, the impact that her eating disorder has had on her relationships, and so much more.If you are personally struggling with any of the issues discussed in this episode, there are resources out there to help. A great first port of call, if you are in the UK, is the charity BEAT: https://www.beateatingdisorders.org.uk/support-services/helplines If you are keen to explore further the ideas around intuitive eating and the Health At Every Size movement, I would recommend taking a look at the work by Laura Thomas PhD (@laurathomasphd), author and founder of the London Centre for Intuitive Eating. Well Undone is hosted and produced by Lydia Allaby.
NEJM Interview: Dr. Alice Shaw on a new model for accelerating the development of promising oncology drugs.
New England Journal of Medicine Interviews
Dr. Alice Shaw is a thoracic oncologist at the Massachusetts General Hospital Cancer Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. T.M. Prowell, M.R. Theoret, and R. Pazdur. Seamless Oncology-Drug Development. N Engl J Med 2016;374:2001-3.
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
ESMO Congress 2012
Dr Alice Shaw talks to ecancer at the 2012 ESMO meeting in Vienna about a randomised phase III study comparing targeted therapy crizotinib with standard chemotherapy in cases of ALK+ lung cancer. ALK+ lung cancer is defined by a genetic abnormality and is present in about 5% of the total lung cancer population. The trial looked to increase progression free survival; results confirmed with a 7.7 month average increase with crizotinib compared to 3 months with standard chemotherapy. The total response rate with crizotinib was 65.3 percent. Side effects that occurred were visual disturbance, nausea vomiting diarrhea, liver irritation, but all were at manageable levels.
ResearchToPractice.com/LCU110 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Alice Shaw, MD, PhD conducted by Neil Love, MD. Produced by Research To Practice.